Paediatric indication for Metoject

The recommended starting dose of Metoject in juvenile arthritis is 10-15mg/m2 once weekly by subcutaneous or intramuscular injection.
The recommended starting dose of Metoject in juvenile arthritis is 10-15mg/m2 once weekly by subcutaneous or intramuscular injection.

Metoject (methotrexate) can now be prescribed in children from the age of 3 years. The injectable methotrexate formulation has been approved for the treatment of polyarthritic forms of severe, active juvenile idiopathic arthritis that have failed to respond adequately to NSAIDs.

View Metoject drug record

Further information: Medac

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more